LEIPZIG, Germany: Many understood the news of the first SARS-CoV-2 vaccines in late 2020 to represent a panacea in the global fight against the pandemic. In reality, a short list of rich countries had already purchased the lion’s share of doses that the makers of these vaccines will be able to produce in 2021—often before clinical trials were even concluded. Many countries are dependent on COVAX, the COVID-19 vaccines global access initiative that aims to distribute doses to healthcare workers and at-risk populations in the developing world. Scientists have pointed out that a lack of equitable distribution could harm global public health.
LONDON, UK: Dental procedures were flagged early on in the SARS-CoV-2 pandemic as posing a high risk for the spread of the virus. The strict infection control measures in place at dental clinics have helped to prevent the spread of the virus in dental settings; however, researchers from Imperial College London and King’s College London have found that careful selection and operation of dental drills could lower the risk of transmission even further.
Like most industries, the dental industry has been severely affected by the SARS-CoV-2 pandemic. The entire European and international economy are facing an enormous recession. Despite the difficult current circumstances, the Association of the German Dental Industry (VDDI) has a positive outlook eight months before the International Dental Show (IDS). Dental Tribune International spoke with Chairman of the Board Mark Stephen Pace about the current situation in the industry and the ongoing preparations for IDS, which is scheduled to take place as planned from 9 to 13 March 2021 in Cologne in Germany.